Register Login

HINGE HEALTH, INC. (HNGE)

Perez Daniel Antonio 🟡 adjusted position in 9.6M shares (3 derivative) of Hinge Health, Inc. (HNGE) at $55.09 ($8.3M) Transaction Date: May 06, 2026 | Filing ID: 000010

Full text
Register to leave comments
  • News bot May 8, 2026, 8:08 p.m.

    🔍 Perez Daniel Antonio (Executive)

    Company: Hinge Health, Inc. (HNGE)

    Report Date: 2026-05-06

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 3
    • Holdings reported: 1
    • Total shares acquired: 150,000
    • Total shares sold: 299,970
    • Total shares held: 9,488,845

    Detailed Transactions and Holdings:

    • Acquired 104,544 shares of Class A Common Stock (Direct)
      Date: 2026-05-06 | Code: C | equity_swap_involved: 0 | shares_owned_after: 140,014.00 | transaction_form_type: 4
    • Sold 104,544 shares of Class A Common Stock at $55.0884 per share (Direct)
      Date: 2026-05-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 35,470.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 45,456 shares of Class A Common Stock (Direct)
      Date: 2026-05-07 | Code: C | equity_swap_involved: 0 | shares_owned_after: 80,926.00 | transaction_form_type: 4
    • Sold 45,456 shares of Class A Common Stock at $55.0503 per share (Direct)
      Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 35,470.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 104,544 shares of Class B Common Stock (Derivative)
      Date: 2026-05-06 | Code: C | equity_swap_involved: 0 | shares_owned_after: 403,901.00 | transaction_form_type: 4 | Footnotes: F4, F4, F4
    • Sold 45,426 shares of Class B Common Stock (Derivative)
      Date: 2026-05-07 | Code: C | equity_swap_involved: 0 | shares_owned_after: 358,445.00 | transaction_form_type: 4 | Footnotes: F4, F4, F4
    • Holds 9,488,845 shares of Class B Common Stock (Derivative)
      Date: 2026-05-06 | Code: H | shares_owned_after: 9,488,845.00 | Footnotes: F4, F4, F4, F5

    Footnotes:

    • F1: The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and his spouse on September 11, 2025.
    • F2: Represents the weighted average sale price. The lowest price at which shares were sold was $55.00 and the highest price at which shares were sold was $55.60. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
    • F3: Represents the weighted average sale price. The lowest price at which shares were sold was $55.00 and the highest price at which shares were sold was $55.16. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
    • F4: Each share of Class B Common Stock is convertible into one share of the lssuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
    • F5: Excludes 4,721,252 performance stock units held by the Reporting Person.

Search

News categories